A recent study published in the journal Biomedicine and Pharmacotherapy raises significant concerns about the long-term safety of aspartame, one of the world’s most widely used artificial sweeteners. Researchers from Spain’s CIC biomaGUNE and the Biogipuzkoa Health Research Institute conducted a year-long study on mice, revealing potential adverse effects on brain and heart health at doses considered safe by current regulatory standards.
The study aimed to address two critical gaps in aspartame research: the brevity of previous studies and the use of unrealistically high doses. Instead, the researchers administered a low, intermittent dose equivalent to approximately one-sixth of the Acceptable Daily Intake (ADI) for humans. Over the course of one year, they monitored the health effects on the mice, uncovering a concerning trend.
Imaging studies indicated that early exposure to aspartame resulted in an initial spike in glucose utilization in the brain, akin to revving an engine. However, by the six-month mark, this pattern reversed, and by ten months, the brains of the aspartame-exposed mice demonstrated a 50 percent decrease in glucose usage compared to control mice. Given that the brain relies heavily on glucose for energy, this reduction points toward a potential metabolic strain rather than a beneficial adaptation.
As the study progressed, initial increases in markers associated with healthy neuron activity were followed by rising levels of lactate. This shift suggests that the brain’s energy management systems were encountering difficulties. As a result, the efficiency of neural circuits may have been compromised, potentially impacting cognitive functions such as learning, focus, and mental endurance.
Mice receiving aspartame also exhibited slower performance in spatial memory tasks, with some unable to complete these tasks by the eight-month mark. Cardiac imaging revealed reduced pumping efficiency and mild enlargement of the heart muscle, indicating that less blood and oxygen were circulated throughout the body with each heartbeat. Even minor changes in circulation can significantly stress organs, including the brain.
Despite these negative findings, the study noted one positive outcome: aspartame-fed mice showed approximately 20 percent less body fat. However, this reduction was accompanied by an increase in visceral fat around organs and a decrease in lean mass, patterns typically associated with poor metabolic health.
While this study used mice as subjects, common in scientific research, the findings highlight the need for further investigation into the long-term effects of low-dose aspartame exposure. Current guidelines may not fully capture the potential risks associated with extended consumption, suggesting that duration of exposure could be a crucial factor.
As consumers increasingly seek sugar alternatives, understanding the implications of artificial sweeteners like aspartame remains essential. Researchers emphasize the importance of continued exploration in this area to ensure public health is not inadvertently compromised.
